Gamma-L-glutamyl-taurine (Litoralon) affects conditioned taste aversion in rats

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Neophobia, an aversion to novel stimuli, is a common behavioral response.
• Dipeptides are small peptides composed of two amino acids.
• Understanding the neurobiological basis of anxiety and aversion is crucial for developing therapeutic interventions.

Purpose of the Study:

• To investigate the anti-aversive and anxiolytic properties of the dipeptide gamma-L-glutamyl-taurine (Litoralon).
• To explore the effects of Litoralon on conditioned taste aversion (CTA) and neophobia in a rat model.
• To compare the effects of Litoralon with diazepam, a known anxiolytic drug.

Main Methods:

• Rats were subjected to a "one-bottle forced choice paradigm" for CTA to assess neophobia.
• Chronic and acute treatments with Litoralon were administered at various doses.
• CTA was evaluated using a "two-bottle test" after LiCl injection.
• The effect of Litoralon on memory retention was assessed by administration prior to the retention test.

Main Results:

• Litoralon (5.0 mg/kg, i.p.) significantly reduced neophobia in rats.
• Chronic Litoralon treatment did not affect the memory of intoxication.
• Acute Litoralon administration did not affect CTA when given immediately after LiCl.
• Litoralon (50.0 µg/kg) and gamma-aminobutyryl ethanolamine phosphate (100-500 µg/kg) significantly increased saccharin intake when given 90 min before the retention test, similar to diazepam.

Conclusions:

• The dipeptides gamma-L-glutamyl-taurine and gamma-aminobutyryl ethanolamine phosphate exhibit anti-conflict properties.
• These effects are likely mediated by a reduction in aversion to phobic stimuli and/or a decrease in anxiety levels.
• The findings suggest potential therapeutic applications for these dipeptides in managing anxiety-related disorders.